Positron Emission Tomography Market worth $3.5 billion

CHICAGO, June 13, 2023 /PRNewswire/ — The positron emission tomography (PET) industry is poised for remarkable advancements in the near future. As a non-invasive imaging technique, PET plays a vital role in diagnosing and monitoring various diseases, including cancer, cardiovascular conditions, and neurological disorders. In the coming years, we can expect significant developments in PET … Read more

Protein Supplements Industry Sets Benchmark High with ESG Goals

SAN FRANCISCO, June 13, 2023 /PRNewswire/ — Consumers are emphasizing sustainability credentials when purchasing food & beverages, prompting protein supplements manufacturers to bank on ESG metrics. Sustainable packaging, environmental preservation, clean label claims, transparency, ethics & compliance and health have become paramount among sustainability-minded consumers. Plant-based and whey-proteins have garnered popularity among Gen Z and millennials, … Read more

VA Oklahoma City Healthcare System Chooses ViewRay’s MRIdian® MRI-Guided Radiation Therapy System

First cancer center in Oklahoma and fourth VA medical center to offer advanced MRI-guided radiation therapy to treat cancer. DENVER, June 13, 2023 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) announced today that the VA Oklahoma City Healthcare System has selected MRIdian MRI-guided radiation therapy system to expand radiation therapy services at the Oklahoma City VA … Read more

Demand for Efficiency in Contract Management Drives Adoption

DUBLIN, June 13, 2023 /PRNewswire/ — The “Global Healthcare Contract Management Software Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global healthcare contract management software market value was USD 1.3 billion in 2022, driven by the need for efficient contract management across the globe. The market size is anticipated to grow … Read more

Frozen vegetables and fruits: do not neglect them!

Consuming 5 fruits and vegetables a day is not always easy. To achieve this, consider varying the pleasures. And among them, frozen products are too often underestimated. Wrongly. Here’s why. Of course, beans, fresh broccoli or freshly picked strawberries and raspberries remain a must in fruit and vegetables. But it is not always possible to … Read more

Global Plasma Derived Therapies Market 2023

DUBLIN, June 13, 2023 /PRNewswire/ — The “Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2023-2027)” report has been added to ResearchAndMarkets.com’s offering. The global plasma derived therapy market is anticipated to reach US$54.35 billion in 2027, growing at a CAGR of 7.20% during the period spanning … Read more

Tetra Pharm Technologies announces successful In-Vitro drug release test of new analgesic compound

The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug – TPT0301. COPENHAGEN, Denmark , June 13, 2023 /PRNewswire/ — In a recent In-Vitro study of TPT0301, Tetra Pharm Technologies’s novel drug delivery technology was compared against more commonly utilized formulations for drug delivery in the oral cavity. A … Read more

Tetra Pharm Technologies gibt erfolgreichen In-vitro-Test zur Wirkstofffreigabe einer neuen analgetischen Verbindung bekannt

Das dänische Biotech-Unternehmen Tetra Pharm Technologies gibt vielversprechende Ergebnisse aus präklinischen Tests seines schmerzlindernden Medikaments TPT0301 bekannt. KOPENHAGEN, Dänemark, 13. Juni 2023 /PRNewswire/ — In einer kürzlich durchgeführten In-vitro-Studie mit TPT0301 wurde die neuartige Arzneimittelverabreichungstechnologie von Tetra Pharm Technologies mit gängigeren Formulierungen für die Verabreichung von Medikamenten in der Mundhöhle verglichen. Für die Freisetzungstests sowie … Read more

Tetra Pharm Technologies announces successful In-Vitro drug release test of new analgesic compound

The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug – TPT0301. COPENHAGEN, Denmark, June 13, 2023 /PRNewswire/ — In a recent In-Vitro study of TPT0301, Tetra Pharm Technologies’s novel drug delivery technology was compared against more commonly utilized formulations for drug delivery in the oral cavity. A … Read more